Last reviewed · How we verify

NCT03722992

The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients

Completed NA Last updated 23 July 2020
What this trial tests

NA trial testing MBSR in Interstitial Cystitis in 14 participants. Completed in 15 March 2020.

Timeline
7 March 2019
Primary endpoint
15 January 2020
15 March 2020

Quick facts

Lead sponsorTriHealth Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment14
Start date7 March 2019
Primary completion15 January 2020
Estimated completion15 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

TriHealth Inc. — full company profile →

Who can join

18 and older, female only, with Interstitial Cystitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective cohort study to investigate differences in the bladder environment (i.e. urinary microbiome) amongst women with interstitial cystitis (IC) before and after undergoing mindfulness-based stress reduction (MBSR) treatment, including yoga and meditation practices.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of MBSR

Trials testing the same drug.

Other recruiting trials for Interstitial Cystitis

Currently open trials in the same condition.

Other TriHealth Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03722992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing